Jonathan Weeks, MD
Family Medicine · Layton, UTNPI 1649364803
Payments from drug & device makers
Across 76 payments — averaging $46.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Inspire Medical Systems, Inc.$74
- Abbott$69
- Otsuka America Pharmaceutical, Inc.$57
- Lilly USA, LLC$57
- Amgen$56
- plus $699 from 25 others
What the payments were for
- Speaking & faculty fees$2,12560%
- Food & beverage$1,43340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 22 | $2,546 |
| Inspire Medical Systems, Inc. | 3 | $74 |
| Abbott | 3 | $69 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Lilly USA, LLC | 4 | $57 |
| Amgen(2 entities) | 3 | $56 |
| Novo Nordisk | 3 | $52 |
| Astellas Pharma US Inc | 3 | $51 |
| Novartis | 2 | $49 |
| Pfizer | 3 | $47 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $42 |
| Merck | 2 | $41 |
| Lundbeck LLC | 2 | $39 |
| Baxter Healthcare | 1 | $37 |
| Indivior Inc. | 1 | $29 |
| Organon | 2 | $26 |
| Sanofi-aventis U.S. LLC | 2 | $24 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $22 |
| Nestle Healthcare Nutrition Inc. | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $21 |
| Johnson & Johnson | 1 | $19 |
| Dynavax Technologies Corporation | 1 | $19 |
| GSK | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Cranial Technologies, Inc | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Acadia Pharmaceuticals Inc | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Nalpropion Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$2,125
How this compares
$3,558 in reported general payments places this provider in the 75th percentile of 928 family medicine providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 19 | $24,241 |
| XareltoRivaroxaban | 19 | $10,062 |
| Xtampza ErOxycodone Myristate | 14 | $9,809 |
| EliquisApixaban | 11 | $6,341 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 165 | $4,513 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 160 | $3,456 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 22 | $1,751 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 12 | $1,515 |
| Omeprazole | 69 | $1,147 |
| Levothyroxine Sodium | 99 | $1,072 |
| Atorvastatin Calcium | 120 | $1,014 |
| Bupropion XlBupropion Hcl | 21 | $1,012 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 39 | $883 |
| Pregabalin | 34 | $833 |
| Losartan Potassium | 72 | $745 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $52 | $24,24119 claims |
| Johnson & JohnsonXarelto | $19 | $10,06219 claims |
| PfizerEliquis | $47 | $6,34111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 928 family medicine providers in Utah.
Other family medicine in Layton
- Marc AndersonLayton$2.8M
- Jeffery DegrauwLayton$921K
- Kurtis WoolfLayton$224K
- Courtney NelsonLayton$190K
- David ButtersLayton$189K
- John HemmersmeierOgden$24.9M
- Judith KirsteinWest Jordan$22.7M
- Matthew JohnstonSalt Lake City$20.9M
- Jared ProbstSalt Lake City$18.8M
- Bryce PetersonBountiful$16M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.